310 results on '"Matsueda Satoko"'
Search Results
2. Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection
3. Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides
4. Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies
5. Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions.
6. Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer
7. Japan Meteorological Agency/Meteorological Research Institute-Coupled Prediction System version 2 (JMA/MRI-CPS2): atmosphere–land–ocean–sea ice coupled prediction system for operational seasonal forecasting
8. Successful ex vivo expansion of tumor infiltrating lymphocytes with systemic chemotherapy prior to surgical resection
9. Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue
10. Data from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
11. Supplementary Methods from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
12. Supplementary Table S5 from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
13. Supplementary Figure S2 from Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer
14. Sapplemental Table 1 from An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy
15. The Global Influence of the Madden–Julian Oscillation on Extreme Temperature Events
16. Personalized Peptide Vaccine as a Novel Immunotherapy Against Advanced Cancer
17. A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer
18. Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases
19. Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression
20. Notch signaling is required for generation of conventional type 1 dendritic cells from human induced pluripotent stem cells
21. Identification of novel Lck-derived T helper epitope long peptides applicable for HLA-A2+ cancer patients as cancer vaccine
22. NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK
23. Generation of cDC-like cells from human induced pluripotent stem cells via Notch signaling
24. Effects of corticosteroids and hyaluronic acid on torn rotator cuff tendons in vitro and in rats
25. Personalized peptide vaccination for cervical cancer patients who have received prior platinum-based chemotherapy
26. PD-1 expression on peripheral blood T-cell subsets correlates with prognosis in non-small cell lung cancer
27. Human dermal fibroblast migration induced by fibronectin in autocrine and paracrine manners
28. Breast cancer cells expressing stem cell markers CD44+ CD24lo are eliminated by Numb-1 peptide-activated T cells
29. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33
30. Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles
31. Identification of HER2/neu-Derived Peptides Capable of Inducing both Cellular and Humoral Immune Responses in HLA-A24 Positive Breast Cancer Patients
32. Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2+ patients with hormone-refractory prostate cancer
33. Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients
34. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination
35. Phase Ii Study of Personalized Peptide Vaccination for Castration-Resistant Prostate Cancer Patients Who Failed in Docetaxel-Based Chemotherapy
36. DELAYED PSA RESPONSES IN PERSONALIZED PEPTIDE VACCINATION FOR CASTRATE-RESISTANT PROSTATE CANCER PATIENTS PHASE II STUDY: 674
37. Immunological evaluation of personalized peptide vaccination in refractory small cell lung cancer
38. Abstract B36: TGFβ blockade and epigenetic modulation for cancer treatment: Efficient breast cancer targeted therapy with TCR-T cell transfer
39. Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients
40. A Peptide Derived From Hepatitis C Virus (HCV) Core Protein Inducing Cellular Responses in Patients With HCV With Various HLA Class IA Alleles
41. Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b + HLA-A24 + patients
42. New Epitope Peptides Derived From Parathyroid Hormone-Related Protein Which Havethe Capacityto Induce Prostate Cancer-Reactive CytotoxicT Lymphocytes in HLA-A2+ ProstateCancer Patients
43. Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24 + non-small cell lung cancer patients
44. Neoantigens retention in patient derived xenograft models mediates autologous T cells activation in ovarian cancer
45. Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice
46. A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma
47. IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides
48. Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase
49. Feasibility study of personalized peptide vaccination for hepatocellular carcinoma patients refractory to locoregional therapies
50. Abstract LB-186: Sustained efficacy of immunotherapy for solid tumors with novel dual CD4/CD8 T cell receptor engineered synergistic combination of hematopoietic stem cells and T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.